The pause of Johnson & Johnson's COVID-19 vaccine in the United States might be days away from coming to an end, according to a new report.
Federal health authorities are "leaning toward" recommending resuming use of Johnson & Johnson's COVID-19 vaccine, "possibly as soon as this weekend," The Washington Post reported on Thursday.
The Food and Drug Administration and the Centers for Disease Control and Prevention on April 13 called for a pause of the vaccine "out of an abundance of caution" due to "six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving" the vaccine.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
On Friday, a meeting of a CDC advisory group is scheduled to take place, and the panel could recommend the vaccine be put back in use. According to the Post, officials will likely not recommend age restrictions for the vaccine but may recommend it come with a warning. That would be a similar step to the one taken by the European Medicines Agency, which said that "unusual blood clots" should be "listed as very rare side effects" of the vaccine, but determined that its benefits outweigh its risks.
CDC Director Rochelle Walensky while speaking to NBC's Today on Thursday said that she didn't want to "get ahead" of the advisory committee, but is "really hopeful that we'll be able to use the vaccine soon." Walensky also noted to the Post that the government has only seen a "handful" of additional blood clotting cases and that "we are not being inundated with things that we are concerned about," while Acting FDA Commissioner Janet Woodcock said the lack of a "huge avalanche" of clotting cases is a "great relief."
-
How will Ford reinvent EV manufacturing to compete with China?Today's Big Question Henry Ford's assembly line system is being replaced
-
The latest entry in Ethan Coen's queer trilogy, a Jeff Buckley documentary and the rare children's horror flick in August moviesthe week recommends The month's film releases include 'Honey Don't!,' 'It's Never Over, Jeff Buckley' and 'Sketch'
-
Switzerland could experience unique economic problems from Trump's tariffsIn the Spotlight The current US tariff rate on Switzerland is among the highest in the world
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
